Issued: 30 jan 2023 @ 10:01
Previous signal: Jan 30 - 09:59
Return: 0.18 %
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease...
|Today's Volume||579 964T|
|Average Volume||763 075T|